(
874
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Asthma phenotypes in children
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Biological severe asthma treatment in Poland – pros and cons of drug programme
-
Biologicals in asthma
-
Biologicals in asthma – from clinical trials to real life
-
Biologicals in asthma – from clinical trials to real life
-
Breathomics in asthma diagnosis
-
Bronchiectasis and severe asthma
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Challenges in food allergy management
-
Diagnosis and Management of hypersensitivity to excipients
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Dietary management of food allergy
-
Difficult to control asthma in adults
-
Difficult to control asthma in children
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
EAACI & ERS joint symposium: new ERS clinical guidelines on diagnosis of asthma in school children
-
EAACI & KAAACI joint symposium: navigating the universe of eosinophilic inflammation in asthma
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Electronic Health in Severe Asthma
-
Endotype-driven interventions in asthma
-
Environmental influences on allergy and asthma development
-
Environmental influences on allergy and asthma development – what is detrimental?
-
Environmental science in allergy and asthma
-
Flash Talks on allergy management
-
Flash Talks on asthma and biologicals
-
Flash talks on asthma
-
Flash talks on asthma II
-
Flash talks on asthma treatment
-
Focus on Patient. Personalised therapy for severe asthma
-
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
-
How to select and follow a biological for asthma and CRSwNP
-
Immunotherapy in severe asthma (AIT)
-
Implementation of telehealth in asthma management: trials and tribulations
-
Late onset T2 asthma – a case study
-
Management of Chronic Urticaria and involving the patient
-
Management of drug allergy
-
May contain traces… management in children with food allergies
-
New Epidemiologic Factors Related to allergy and asthma
-
Novel analytical tools to endotype asthma and allergic diseases
-
Novel insights into rhinitis management
-
Novel therapeutic approaches in severe asthma
-
Novel therapeutic targets in allergic diseases and asthma – from common clues to a universal solution
-
Occupational allergy and asthma to animals – Recent developments
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
Severe Asthma and COVID-19
-
The basics of severe asthma – biomarkers
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
-
The role of EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
Update of pathogenesis and management of nasal polyposis
-
Updates in [severe] asthma in adults
-
Utility of Molecular Allergology in supporting management of patients sensitised to cross-reactivity allergens
-
Viral infection and asthma
-
What do clinical trials and real world tell us about allergy and asthma treatment?
-
Asthma management during the COVID-19 pandemics
-
Management of asthma exacerbations
Show more Event Resources (61)Show Less-
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria Taskforce
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task Force
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper
-
A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
-
A systematic review and meta-analysis on absolute eosinophil counts and the risk of asthma in preschool children with wheezing: An EAACI Task Force Report
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) – a EAACI position paper
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants – An EAACI Position Paper
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paper
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children – EAACI position paper
-
Diagnosis and management of food allergy-induced constipation in young children—An EAACI position paper
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly
-
Management of ocular allergy
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases
-
Omics technologies in allergy and asthma research: An EAACI position paper
-
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research – The European Strategic Forum on Allergic Diseases
-
The One Health approach for allergic diseases and asthma
-
Influenza burden, prevention, and treatment in asthma – A scoping review by the EAACI Influenza in asthma task force
Show more Position Papers (25)Show Less-
-
Better defining the roles of non-allergy specialists healthcare professionals in the management of allergic disorders
-
Clinical diagnosis and management of severe cutaneous adverse drug reactions (SCARs) in children: an ENDA/EAACI pediatric task force report
-
EAACI position paper on the diagnosis and therapeutic management of allergic bronchopulmonary aspergillosis (ABPA)
-
European network for the PHenotyping of OCcupational ASthma – E-PHOCAS-Phase II 2024
-
Exercise and physical activity for asthma management: an EAACI task force position paper
-
Immunometabolism in allergy and asthma – AllerIMMET
-
Joint Task Force on the role of residential greenness exposure in the multifactorial pathway towards allergy and asthma (EAACI statement)
-
Management of adverse reactions to anticoagulants
-
Managing the upcoming increase in asthma prevalence cause by the war in Ukraine
-
Occupational Mite Allergy and Asthma (OMAA)
-
Phenotypes and endotypes of pediatric asthma
-
Prevalence and predictive factors for co-morbid CRS and asthma
-
Prevalence and predictive factors for co-morbid CRS and asthma
-
Principles for targeting eicosanoids in the treatment of asthma and allergic diseases
-
Public outreach for immunological mechanisms in allergies and asthma
-
Recommendations for prevention and management of adverse reactions to biologics
-
Roadmap for the management of EoE
-
The new nomenclature for allergic diseases and asthma
-
The use of omic sciences in asthma and allergy clinical practice
-
Therapeutic education for patients with asthma
-
Under- and over-diagnosis of asthma
-
Use of biologics in the management of rare eosinophilic diseases
Show more Task Forces (20)Show Less-
-
Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & Prevention
-
Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2
-
Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthma
-
Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in Beijing
-
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments
-
Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in Daegu
-
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
-
DGAKI statement on asthma and COVID-19
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
-
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: data from the DA‐COVID‐19 registry
-
Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper
-
Shielding against SARS-CoV-2 infections is not justified in children with severe asthma 
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemic
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section
-
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry
Show more Covid-19 (14)Show Less-
-
A New Age in the Management of Pediatric Atopic Dermatitis: Evolution of Disease Understanding and Treatment Opportunities
-
A unified approach: Improving patient outcomes in severe asthma and comorbid eosinophilic diseases
-
Activated phosphoinositide 3-kinase δ syndrome (APDS): Challenges in diagnosis, management and recent advances in treatment
-
Advancing the management of CMPA with HMO: Priming the immune system
-
Breaking new ground: A closer look at Type 2 Inflammation in pediatric asthma
-
Can we break the cycle of lung function decline and asthma exacerbations driven by type 2 inflammation in asthma?
-
Championing change: Is elimination of oral corticosteroid use in asthma achievable today?
-
Childhood Asthma and the Impact of Type 2 Inflammation
-
Chronic spontaneous urticaria: defining the pathway to successful management
-
Filling the gaps in asthma care
-
IgE in asthma and nasal polyposis: your questions answered
-
Managing severe asthma and CRSwNP: Through the lens of Type 2 Inflammation
-
Strengthening the immune system to reduce asthma risk: paving the way to the future?
-
TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascade
-
Targeted therapy for patients with severe eosinophilic asthma – an interactive conversation with experts
-
Relegating OCS to last resort: Creating a paradigm shift in asthma management
Show more Sponsored Symposia (14)Show Less-
-
Diagnosis and management of hypersensitivity reactions due to biologics
-
Diagnosis of T2 asthma in adults
-
Diagnosis of T2 asthma in the pediatric population
-
Food Allergy and Anaphylaxis: Latest updates in the diagnosis and management of food allergy
-
How to apply AI models in Asthma
-
JAK Inhibitors for Asthma
-
Management of Common Drug Allergies
-
Targeted treatment of T2 asthma
-
Tips & Tricks and Tools for Angioedema Management in Routine Clinical Practice
Show more Courses (7)Show Less-
-
EAACI Biologicals Guidelines – Recommendations for severe asthma
-
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
-
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma
-
EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma
-
EAACI guidelines on environmental science in allergic diseases and asthma
-
The international EAACI/ GA²LEN/ EuroGuiDerm/ APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
-
The international WAO/ EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
Show more Guidelines (5)Show Less-
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
ERS/EAACI statement on adherence to international adult asthma guidelines
-
The One Health approach for allergic diseases and asthma
Show more Consensus Documents (2)Show Less-
Website
Collapse
-
“Comprehensive Allergological Evaluation and Management of Severe Anaphylaxis to Vespid Venoms: A Case Study”
-
131 genetic loci highlight immunological pathways and tissues in asthma and nasal polyposis
-
17q21 locus rs7216389 polymorphism and asthma risk: a meta-analysis
-
5y follow up study of single low dose challenge in the diagnosis and management of cow’s milk allergy in infants
-
A 12 months real-life prospective study of lung function in patients with severe eosinophilic asthma undergoing therapy with ics/laba, lama, and anti IL5/5R monoclonal antibody
-
A case of Pneumothorax as first manifestation of asthma
-
A case of life-threatening asthma triggered by mood disorder and sexual abuse
-
A cost effective, self-sustaining, and effective way of improving asthma understanding in undergraduate students
-
A mechanosensitive cytoskeleton protein talin2 involved in asthma pathogenesis
-
A patient-centric approach to chronic rhinosinusitis with nasal polyps (CRSwNP): developing tools to improve disease management and outcomes
-
A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma
-
A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma
-
A stepwise approach to the management of a patient with celiac disease and multiple IgE-mediated food allergies
-
AI, Biomarkers, and Big Data – Is Precision Medicine the Future of Asthma Care?
-
AI-derived trajectories of wheezing and asthma in children: a systematic review
-
Accuracy of changes in fractional exhaled nitric oxide for diagnosing occupational asthma
-
Adherence to a sustainable and healthy dietary pattern and its impact on asthma and airway inflammation
-
Adherence to a sustainable and healthy dietary pattern and its impact on asthma and airway inflammation
-
Adherence to the Planetary Health Diet and Asthma Risk in Children: Evidence from a Birth Cohort
-
Adult Gut Microbiota and Metabolomics in Different Phenotypes of Asthma
-
Advanced glycation end-products in formulas for the dietary management of cow’s milk protein allergy
-
Advancements and Key Insights in Chronic Rhinosinusitis (CRS) Management
-
Advances in drug allergy diagnosis and management
-
Advances in epicutaneous immunotherapy for the management of patients with food allergy
-
Advancing AIT in the clinical management of children with respiratory allergy
-
Advancing Asthma Diagnosis: Integrating Exhaled Biomarkers and Deep Neural Networks (DNNs) in a POC Breath Test
-
Advancing Asthma Diagnosis: Integrating Exhaled Biomarkers and Deep Neural Networks (DNNs) in a POC Breath Test
-
Advancing Diagnosis and Management of Hereditary Angioedema in Brazil: Insights from the first 704 patients of a Multicenter Registry
-
Advancing insights in urticaria: risk factors and long-term management strategies
-
Adverse reactions to biologicals in severe asthma
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19
-
Allergic Asthma in Children: The Hidden Role of Cockroaches
-
Allergic asthma
-
Allergic asthma – a challenge no more
-
Allergic asthma in a sample of dairy farmers
-
Allergy asthma and a sport
-
An explainable machine learning approach on early predictors of persistent childhood asthma and allergic rhinitis
-
An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)
-
Analysis of clinical and anamnestic risk factors of bronchial asthma in children
-
Analysis of exacerbating factors of pediatric asthma before and after the COVID19 pandemic
-
Anti-IgE in the management of food allergy: pros and cons
-
Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years
-
Apply cluster analysis and machine learning to identify phenotypes of work-related asthma
-
Applying allergen threshold to dietary management of food allergy
-
Approaches to the management of patients with airway diseases and comorbid non-allergic conditions
-
Approaching CRSwNP and asthma with biologicals – RWE data
-
Apps and Wearables in Pediatric Allergy Management
-
Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma
-
Association between 25-hydroxy vitamin D and pulmonary function among obese and asthma children
-
Association between 25-hydroxy vitamin D and pulmonary function among obese and asthma children
-
Association between Asthma and Risk of Respiratory Syncytial Virus-Acute Respiratory Infection in Adults 50 Years or Older Before and After the Covid 19-Pandemic in a Midwest Region of the U.S
-
Association between changes in blood eosinophil levels and alterations in olfactory function in asthma
-
Association of PTGS2 rs689466 polymorphism with asthma susceptibility among asthmatic of West Bengal, India
-
Association of anthropogenic heat with asthma and related symptoms among children in China: a novel index reflecting climate change
-
Asthma
-
Asthma & Biologicals
-
Asthma 01
-
Asthma 02
-
Asthma 03
-
Asthma 04
-
Asthma 05
-
Asthma 06
-
Asthma 07
-
Asthma 08
-
Asthma 1
-
Asthma 2
-
Asthma 3
-
Asthma 4
-
Asthma 5
-
Asthma 6
-
Asthma 7
-
Asthma 8
-
Asthma 9
-
Asthma Comorbidities – do they add more cost, A 3-year follow-up study in Réunion Island
-
Asthma Digital Health Tools and Opportunities for ArtificiaI Intelligence – Based Risk Prediction
-
Asthma Right Care – the growth of the social movement to reduce reliance on episodic care and to increase long term safe and person-centred care
-
Asthma and ABPA: Similarities and Differences
-
Asthma and Climate Change: A Five Year Study of Camp Wheez
-
Asthma and comorbidities
-
Asthma and nutrition
-
Asthma beginnings: Unraveling the early triggers
-
Asthma endotypes in the era of data science boom!
-
Asthma exacerbations and death after recovery from COVID-19: A nationwide long-term follow-up study
-
Asthma exacerbations in the pediatric emergency area: evaluation and prospects for improvement of pre-hospital care
-
Asthma in Brazilian children and adolescents
-
Asthma in children: Personalization and innovation for the future
-
Asthma in the Intermediate/Intensive Care of a Central Hospital
-
Asthma inception and trajectory through lifecourse
-
Asthma increases short-time sickness absence and presenteeism in young adults
-
Asthma is associated with increased sickness absence among young adults
-
Asthma monitoring in children 2024 – the pearls from the PearL Think Tank
-
Asthma phenotype markers did not affect allergen immunotherapy effectiveness
-
Asthma remission in EGPA patients: applicability and concordance of the main international guidelines
-
Asthma remission: what is it and how can it be achieved?
-
Asthma response in patients with allergic rhinoconjunctivitis to grass pollen using an environmental exposure chamber
-
AstraZeneca – Transforming severe asthma respiratory care: the clinical experience
-
At the core of allergy and asthma pathology: exploring the connection between airway epithelium and effector cells
-
Atopy as a reflection of inborn errors of immunity: strategies for effective management
-
Baseline Characteristics of Patients with Severe Asthma in Spain according to biological treatment use: BREATHE study
-
Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry
-
Baseline Predictors of Multicomponent Clinical Remission Following Dupilumab Treatment in Patients With Moderate-to-Severe Asthma
-
Baseline disease burden in severe asthma patients treated with biologics, and eligible but not treated: Spanish patients in the ISAR Registry
-
Benefits and pitfalls of high dose ICS in asthma
-
Benefits of non-invasive methods in the diagnosis of occupational asthma: example of asthma due to ammonium persulphate in a hairdresser
-
Benralizumab as treatment in a patient with Near-Fatal Asthma exacerbation
-
Benralizumab effectiveness in severe eosinophilic asthma patients from Central Eastern Europe and Baltics: BREEZE study
-
Benralizumab reduces annual cumulative OCS dose while improving asthma control and quality of life in severe eosinophilic asthma: Real-World Evidence from the AURORA study
-
Best tools for allergy and asthma translational research
-
Beyond the future – perspectives in the diagnosis and treatment of allergy and asthma
-
Biologics and airway remodeling in asthma
-
Biologics have Solved the Problem of Type 2 Asthma
-
Biomarker-guided approach for treatment of preschool asthma
-
Biomarkers for asthma and allergic diseases
-
Biomarkers shaping severe asthma phenotypes
-
Blueprint Medicines – Transforming management of indolent systemic mastocytosis with precision medicine
-
Breakthroughs in management of Hereditary Angioedema
-
Breast-feeding is inversely associated with asthma and IgE sensitisation up to young adulthood
-
Briquilimab, an Anti-Human CD117 Antibody, Effectively Treats Cockroach Allergen-Induced Asthma Model Elicited in Mice Expressing Chimeric Human/Mouse CD117
-
Bronchiolitis and future risks for childhood asthma
-
Burden and subtypes of early-life infections increase the risk of asthma and adverse lung function
-
Can Artificial Intelligence-Based Large Language Models Provide Accurate and Reliable Information to Asthma Patients? A Comparative Analysis with Expert Insights
-
Can Sensory Processing Disorder Be A Comorbidity Of Allergic Asthma In Children?
-
Can the natural progression from allergic rhinitis to asthma be changed ?
-
Case report of an occupational disease in a veterinarian with allergic asthma
-
Causes of death in patients diagnosed with severe asthma in our area- 10 years observational study
-
Challenges for transitional care for adolescents and young adults with asthma – from the healthcare professionals’ perspectives
-
Challenges in Anaphylaxis management
-
Changes in small airway physiology measured by impulse oscillometry in subjects with allergic asthma following methacholine and inhaled allergen challenge
-
Changes in the awareness on anaphylaxis and asthma exacerbation: Education for 119 emergency department paramedics in Korea
-
Characteristics of Patients with Uncontrolled Severe Asthma Undergoing Biological Therapy Based on Spirometric Response: Our Experience
-
Characteristics of Severe type 2 Asthma Patients in China: A Retrospective Observational Study
-
Characteristics of patients with severe asthma undergoing biological treatment at a reference center
-
Characterization of Patients With Asthma Initiating Dupilumab Treatment in a Real-World Setting: The RAPID Registry
-
Chemical product exposure in professional cleaners and its relationship with occupational asthma
-
Childhood asthma and allergy is related to accelerated epigenetic aging in the LISA birth cohort
-
Classification, early determinants and long-term impact on asthma of the IgG responses to rhinovirus VP1 (RV-VP1): a longitudinal study in two birth cohorts
-
Classifying the unclassifiable: diagnosis, characterization, and management of adults with unclassified primary antibody deficiency (unPAD)
-
Clinical Characteristics and Predictors in Patients with Difficult-to-Treat Asthma
-
Clinical Characteristics of Patients with Severe Asthma by Different Elevated Biomarkers Classifications: Patients from Spain in the ISAR Registry
-
Clinical Effectiveness of Tezepelumab on Upper and Lower Airway Symptoms in Patients with Asthma and Co-morbid Nasal Polyposis
-
Clinical Management
-
Clinical Remission in Asthma and its Correlation with Nasal Comorbidities
-
Clinical and Healthcare Resource Use in Patients with Asthma and Low-Eosinophil Counts
-
Clinical and Inflammatory Characteristics of Occupational Asthma Caused by Persulfate Salts in Hairdressers: A Multicenter Cohort Study
-
Clinical effects of dupilumab in patients with rhinosinusitis, nasal polyposis, and severe uncontrolled asthma with t2 phenotype, after 12 months of treatment
-
Clinical impact of Immune mechanisms driving asthma
-
Clinical implications of biologic therapies in comorbid severe asthma and CRSwNP
-
Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science
-
Clinical profile and management of pediatric hereditary angioedema in resource constrained settings: our experience from a single centre in North India
-
Clinical profile and management of pediatric hereditary angioedema in resource constrained settings: our experience from a single centre in North India
-
Clinical profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)
-
Clinical trials on Asthma and Rhinitis
-
Closing Remarks and Summary: Closing Gaps in HAE Management
-
Comparative Risk of Neuropsychiatric Adverse Events Associated With Leukotriene-Receptor Antagonists Versus Inhaled Corticosteroids Among Asthma Patients
-
Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children
-
Comparison of the proteomic profile in tears between patients with severe atopic dermatitis and severe asthma treated with Dupilumab
-
Comprehensive Analysis Of Pediatric ICU Admissions For Severe Acute Asthma Over A Decade
-
Correct Inhaler Technique as a Key Element of Asthma Management: Post-Education Evaluation of Patients’ Knowledge
-
Correlation between Fractional exhaled nitric oxide and pulmonary function test in children with asthma
-
Cracking the code on asthma prevention
-
Current concepts on management of AD
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
DBV Technologies – Peanut allergy management in motion!
-
DBV Technologies: Contemporary management of food allergy
-
Decrease in Eosinophil-Derived-Neurotoxin upon mepolizumab is associated with asthma improvement
-
Decrease in New-Onset Asthma During the COVID-19 Pandemic
-
Defining Asthma Remission: Challenges and Potentials
-
Descriptive Analysis of Health-Related Physical Activity Patterns Among Korean Adolescents Diagnosed with Asthma
-
Desensitization Decoded: Personalized pediatric drug allergy management
-
Detection and management of milk allergy
-
Determinants of fractional exhaled nitric oxide (FeNO) among workers at risk of developing occupational asthma in high-risk occupational settings
-
Development and implementation of an intelligence platform for management of allergen immunotherapy in China
-
Development of AsthmaSense: A Web-Based Predictive Tool for Childhood Asthma Risk Assessment
-
Development of a Validated, Updated North American Anaphylaxis Management Plan
-
Diagnosing Asthma with an Exhaled Breath Test at the Point of Care (POC)
-
Diagnosis and Management of LTP allergy: results of a survey addressed to Italian Allergists
-
Diagnosis and management of Eosinophilic Esophagitis
-
Diagnosis of allergic asthma
-
Diagnosis of exercise-induced asthma
-
Diagnosis, management and follow-up of a fish FPIES series: room from improvement
-
Dietary management of food allergy: What do I do?
-
Differential study of whole genome expression profiles of peripheral blood mononuclear cells in children with dust mite specific immunotherapy for asthma
-
Disease Burden of Severe Asthma Patients Treated with Medium and High Doses of ICS: A Regional Database Analysis from China
-
Dissecting the molecular mechanisms underlying TSLP-driven non-type 2 inflammatory responses in severe asthma
-
Distribution of Patients with Asthma According to the New Immune Response Classification
-
Does severe asthma exist in preschool children?
-
Dual role of MAPK13 in epithelial barrier integrity and mucus production in asthma
-
Dupilumab Improves Lung Function and Reduces Exacerbation Frequency and IgE Levels in Patients with Asthma and Allergic Bronchopulmonary Aspergillosis (Phase 2 LIBERTY ABPA AIRED Study)
-
Dupilumab Reduces FeNO levels and Exacerbations and Improves Asthma Control with Inhaled Corticosteroid Withdrawal: a Phase 2 Study
-
Dupilumab Reduces Seasonal Exacerbation Rates in Children With Type 2 Asthma With or Without Evidence of Allergy
-
Dupilumab Reduces Systemic Corticosteroids in Children With Uncontrolled Moderate-to-Severe Asthma Regardless of Exacerbation History
-
Dupilumab as a New Therapeutical Approach in Patients with Severe Seasonal Asthma Caused by Olive Pollen Sensitization
-
Dupilumab-Induced Diffuse Eosinophilic Drug Rash with Hypereosinophilia in a Patient with Idiopathic Pulmonary Fibrosis and Severe Asthma Exacerbation: A First Case Report
-
Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions
-
Dupilumab: Improved Asthma Control and Quality of Life in Pediatric Patients – A Real-World, Single-Center Study
-
EAACI & APAPARI Joint Symposium : Emerging concepts in the management of food allergies
-
EAACI & APAPARI joint symposium – Novel approaches to the management of fish allergy
-
EAACI & IPCRG Joint Symposium : Improving the Delivery of Person-centred asthma care in global primary care
-
EAACI nomenclature for allergy and asthma
-
Early Real-World Outcomes of Tezepelumab in Severe Asthma Patients Unresponsive to Prior Biologics
-
Early gut microbiota in association to IgE-mediated asthma in young adults
-
Effect of baseline long-acting muscarinic antagonist (LAMA) use on inhaled corticosteroid dose reduction in patients with severe eosinophilic asthma treated with benralizumab: SHAMAL post-hoc analysis
-
Effectiveness of Dupilumab in improving Quality of Life in patients with “steroid-resistant” asthma and severe atopic dermatitis
-
Effectiveness of Tezepelumab in uncontrolled severe asthma. ADVANCAT (Advancing severe asthma care with Tezepelumab in Catalonia)
-
Effects of Using Filters on indoor air quality for asthma patients under arid conditions of United Arab Emirates
-
Effects of hypoallergenic formula containing synbiotics in the management of cow’s milk allergy: results of a global healthcare professional and parent survey
-
Efficacy of Dupilumab in patients over 50 years of age with severe asthma
-
Efficacy of Omalizumab in Food Allergy Management in a Patient with Chronic Spontaneous Urticaria
-
Efficacy of Rilzabrutinib on Asthma Control: Results From a Double-Blind Placebo-Controlled Phase 2 Study
-
Efficacy of Rilzabrutinib on Asthma Quality of Life: Results From a Double-Blind Placebo-Controlled Phase 2 Study
-
Efforts to Eliminate Childhood Asthma Death in China
-
Elevating patient treatment outcomes in Severe Asthma
-
Elevating patient treatment outcomes in Severe Asthma & comorbid CRSwNP
-
Emerging insights into food allergy mechanisms and clinical management
-
Emerging therapies and approaches for achieving remission in severe asthma
-
Environmental impact of asthma treatment
-
Environmental impact of asthma treatment: prioritizing patient outcomes and reducing environmental burden
-
Eosinophil granule proteins as a biomarker for managing asthma
-
Eosinophilia over dupilumab treatment in asthma patients: a multicentric retrospective study
-
Eosinophilic Pneumonia Triggered by Toxocara canis in a Patient with Kartagener Syndrome: A Case Report Highlighting Diagnostic Challenges and Interdisciplinary Management
-
Eosinophilic diseases: from nasal polyposis, eosinophilic asthma to EGPA (Eosinophilic Vasculitis with PolyAngioitis), evaluation of possible biomarkers of disease evolution
-
Epidemiology and clinical management of drug allergy
-
Epigenome-wide association study of asthma exacerbations in European populations
-
Evaluation of remission of Severe Asthma treated with monoclonal antibodies according to different definitions: a single center cohort
-
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease
-
Evaluation of the Pediatric Patients with Severe Eosinophilic Asthma Treated with Mepolizumab
-
Evaluation of the Safety of Mixed Tree Nut Oral Food Challenges in the Management of Tree Nut Allergy
-
Evaluation of the level of asthma control in the pulmonology-phtisiology department of the Ignace Deen University Hospital
-
Evaluation of the tolerability of the administration of subcutaneous immunotherapy in a cluster schedule, in patients with rhinoconjunctivitis and/or asthma with sensitization to Olea europaea with or without sensitization to grasses
-
Evolution in Acute Management of Hereditary Angioedema due to C1 inhibitor deficiency (HAE-C1INH)
-
Evolving Strategies in the Management of IgE-Mediated Egg Allergy: A Systematic Review
-
Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Exosomal Signaling and Mitochondrial Transfer Reprograms T Helper Cell Function in Human Asthma
-
Exploring a beta-lactoglobulin-based food for specific medical purposes (FSMP) for dietary management of chronic inflammation in atopic dermatitis: insights from mouse studies
-
Exploring association between lung function, asthma and epigenetic predisposition to obesity
-
Exploring stem cells for allergy and asthma treatment: Potential without certification
-
Exploring the Potential of Serum Periostin and YKL-40 as Airway Remodeling Markers for Airway Hyperresponsiveness in Pediatric Asthma
-
Exploring the clinical management of Eosinophilic Esophagitis
-
Exploring the relationship between 6 minutes walk test (6MWT) performance and lung function in Severe Asthma and CRSwNP
-
FPIES Management
-
FPIES diagnosis and management
-
Features of Perioperative Hypersensitivity Reactions Manifestations in Children with Bronchial Asthma
-
Features of the course of the antenatal and neonatal period of children with bronchial asthma
-
Finding the right asthma patient for LAMA therapy
-
First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma
-
Fish allergy and tolerance: a case of safe management thanks to multiplex MADX-ALEX2 test
-
Flash talks on Allergic Response Management
-
Flash talks on Asthma
-
Flash talks on Asthma
-
Flash talks on Pediatric Asthma
-
Food Allergy Management
-
Food Allergy: From prevelance, therapeutic options and management of anaphylaxis.
-
Food Allergy: New Guidelines for Diagnosis and Management
-
Food allergy: Management of complications
-
Formula milk replacements : management in food allergy
-
Frequency of Herpes Zoster in Asthma and Associated Factors
-
Frequency of SNPs associated with pharmacogenetic phenotypes in Asthma in two Colombian populations
-
Frequency of asthma exacerbations in Mexican patients with Vitamin D insufficiency/deficiency and dyslipidemia
-
From Symptoms to MBPT: A Machine Learning Approach to Asthma Diagnosis
-
From adults to children: Translating severe asthma research to pediatrics
-
From suspected poorly controlled asthma to allergic bronchopulmonary aspergillosis
-
Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation
-
Furan fatty acid metabolites in pregnant women and newborns are associated with risk of childhood asthma
-
GSK – Elevating patient treatment outcomes in severe asthma and CRSwNP
-
GSK – Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Genetic Associations of TSLP SNPs with Asthma Susceptibility and Severity
-
Genetic associations with asthma in the kazakh population
-
Genetic polymorphisms associated with the development of asthma in the Kazakh population
-
Genome-wide association study identifies CACNA2D3 associated with asthma and atopic dermatitis multimorbidity in children
-
Global Initiative for Asthma (GINA) Guidelines
-
Grape polyphenols increase the concentration of BPI in asthma patients who have had SARS-CoV-2
-
Grape polyphenols reduce the concentration of LPS in patients with asthma
-
Greener practice and patients’ outcomes in asthma
-
Group A – Asthma
-
Gut Microbiota and Phenotypes of Childhood Asthma
-
Health Care Situation in the Treatment of Uncontrolled GINA 4/5 Asthma Patients in Germany: 2019 vs. 2022
-
Healthcare Provider Perspectives on Management of European Patients with Systemic Mastocytosis
-
Hot Topics in Pediatric Asthma
-
House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents
-
How Food Allergen Sensitization Influences Asthma in Children with Atopic Dermatitis
-
How to manage asthma patients in the clinic
-
Human milk oligosaccharides 3’SL and 6’SL suppress airway hyperreactivity, while only 3’SL also reduces airway inflammation in a murine allergic asthma model
-
Hypoallergenic and anti-remodeling effect of a hybrid protein in a murine model of chronic asthma induced by Dermatophagoides pteronyssinus
-
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
-
IL-13 and airway calibre codetermine exhaled nitric oxide levels in type-2 asthma patients
-
IgE reactivity profile to respiratory and food allergen components among patients with allergic rhinitis with and without asthma
-
IgG autoantiboides in asthma
-
Immune Skewing in pediatric asthma – clinical consequences
-
Immune skewing and the impact on treatment response in adult asthma
-
Immuno-metabolic reprogramming of bronchial epithelium in asthma
-
Immuno-metabolic reprogramming of bronchial epithelium in asthma
-
Immunodeficiency spectrum in patients with severe asthma receiving biologicals
-
Immunodeficiency spectrum in patients with severe asthma receiving biologicals
-
Immunological changes induced by a salsola kaly extract in patients with allergic rhinitis or rhinitis and asthma
-
Immunonutrition: Bridging Nutrition and Immune Health in Allergy Management
-
Impact of Asthma on Hospitalization and Antibiotic Courses in Common Variable Immunodeficiency Respiratory Infections
-
Impact of Immunogenicity on Clinical Outcomes in Patients from a Severe Asthma Unit Treated with Mepolizumab
-
Impact of Switching from Omalizumab to Dupilumab in Severe Asthma Patients: A Retrospective Evaluation of Efficacy and Inflammatory Biomarkers
-
Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset
-
Impact of air pollutants, influenza infection on asthma exacerbation
-
Impact of asthma as a chronic disease on the quality of life of the patient and his family
-
Impact of asthma on severe food-induced allergic reactions: a systematic review and meta-analysis
-
Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study
-
Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study
-
Impact of mepolizumab on exacerbations and maintenance OCS use in patients with asthma and baseline blood eosinophil counts of ≥150–<300 cells/μL in the REALITI-A study: 2-year outcomes
-
Impact of overweight and obesity on clinical remission and Response to Biologics in Severe Asthma Patients
-
Impact of the new UK guidelines on the emergency management of anaphylaxis at two hospitals
-
Improvement in Lung Function with Rademikibart in Eosinophilic Driven, Type 2 Asthma
-
Improving NMBA hypersensitivity management using CD203c activation marker in basophil activation tests
-
Increase in airway resistance and respiratory bronchial reactivity is accompanied by cellular and antibody Type 2 immune response in a mouse model of asthma induced by Der p 23 allergen
-
Indirect case matched comparison of dupilumab versus benralizumab on mannitol airway hyperresponsiveness in type 2 high severe asthma
-
Individual management of atopic dermatitis according to phenotypes and co-morbidities
-
Inequalities on environmental exposures and allergic diseases and asthma
-
Infective asthma exacerbations in severe asthmatic patients receiving biological drugs
-
Inflammatory and Oxidative Stress Markers in Serum, Urine and Exhaled Breath Condensate: Relationship between Asthma and Obesity in Children
-
Inflammatory cytokine-mediated airway remodeling in asthma
-
Inflammatory phenotypes of severe asthma from sputum and plasma proteomic profiles
-
Influence of selected cytokines and chemokines on the ventilation efficiency in spirometric examination, in patients with asthma post-COVID-19
-
Inhaled corticosteroid-related neuropsychiatric side effects in children with asthma
-
Innate Immune Memory and Metabolic Reprogramming in the Lower Airway Epithelium of Patients with Allergic Asthma
-
Innovating allergy and asthma education: building a resilient future for global health
-
Innovative treatments and strategies for food allergy management
-
Insights from the BREATHE Study: Comorbidity Burden and Biomarker Trends in Severe Asthma Patients
-
Insights into Hereditary Angioedema management
-
Integrating Breathomics with CPET: A Breath-Taking Approach to Exercise-Induced Asthma Monitoring
-
Interindividual variability in serum concentration of montelukast and metabolites in asthma patients
-
Interleukin-17A gene polymorphism contribute to the elderly asthma susceptibility: evidences from a case-control study
-
Intracellular cell-mediated cell-to-cell communication exacerbates the pro-inflammatory progression of asthma
-
Investigating the Role of IL17 rs763780 Gene Polymorphism Associated with Asthma among Population of West Bengal, India
-
Investigating the Role of TBXA2R rs4523 Gene Polymorphism Associated with Asthma among Population of West Bengal, India
-
Investigation Of Treatment Responses And Clinical Characteristics Of Patients With The Late-Onset Asthma Phenotype Under Biological Treatment
-
Investigation of Asthma Characteristics in Women with Generalized Periodontitis and Polycystic Ovary Syndrome
-
Investigation of the predictors of asthma phenotypes (atopic and non-atopic asthma) using machine learning and traditional statistical techniques
-
Involvement of Janus kinase (JAK)-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells (ILC2s) in asthma
-
Is Mediterranean Diet Best for Asthma Prevention?
-
Is remission an adequate therapeutic goal for severe asthma
-
Is there a role for a social movement approach. Lessons from Asthma Right Care
-
Is there still a role for oral corticosteroids in the management of CRS
-
Knowledge, attitudes and practice patterns in chronic spontaneous urticaria management among Italian General Practitioners: Baseline data from the BRIDGE implementation science study
-
Lessons Learned from the Diagnosis and Management of a female pediatric patient with NCF2 Mutations and Chronic Granulomatous Disease
-
Lessons from asthma questionnaires
-
Levels of total IgE vs. specific IgE during childhood for defining and predicting T2-high asthma
-
Lichen Planus induced by treatment of severe eosinophilic asthma with biological therapy
-
Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis
-
Lipid metabolism and allergic asthma severity
-
Long-Term Efficacy of Mepolizumab at 5 Years in Patients with Severe Asthma
-
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma
-
Long-term Qipian® administration prevents airway inflammation in ovalbumin-induced mouse asthma via restoring Th1/Th2 balance and modulating gut microbiota
-
Long-term dupilumab effect on lung function in subgroups of pediatric patients with uncontrolled asthma
-
Long-term outcome of work-related asthma
-
Low education level, occupational exposure and no medication use increase the risk of uncontrolled asthma in Chinese patients: findings from baseline data of a multi-centre, single-arm study (CARE FOR ALL)
-
Lung Function Improvement is Associated With Better Asthma Control in Adolescents and Adults Aged 12 Years and Older With Moderate-to-Severe Type 2 Asthma: A Post Hoc Analysis of QUEST
-
Lung Function Responder Rates in the VOYAGE study in Children with Moderate-to-Severe Type 2 Asthma Receiving Dupilumab at Week 52
-
Lung function and exacerbations by different type 2 inflammation criteria in a general asthma population
-
Lymphocyte profile and asthma control during the treatment with benralizumab in real life
-
Management
-
Management and disease burden of children and adults with severe IgE-mediated food allergy: Are adults the lost population?
-
Management chronic urticaria in children
-
Management decisions in 13 patients with hypersensitivity reactions to chemotherapy agents
-
Management of Atopic dermatitis patients under the scope of Treat to target (T2T)– Real world data of remission induction stage
-
Management of Atopic dermatitis patients under the scope of Treat to target (T2T)– Real world data of remission induction stage
-
Management of Chronic Spontaneous Urticaria and Atopic Dermatitis with Omalizumab: A Case Report Highlighting Efficacy and Emerging Challenges
-
Management of Contact Dermatitis in Pediatric Type 1 Diabetes: A Therapeutic Protocol with Topical Pimecrolimus
-
Management of Eosinophilic Esophagitis as a side effect of food oral immunotherapy
-
Management of adverse reactions to platinum based drugs in our unit in the last year
-
Management of allergic rhinitis in children
-
Management of atopic dermatitis: What would you have done?
-
Management of beta-lactam induced urticaria
-
Management of cow’s milk allergy in children
-
Management of delayed drug hypersensitivity reactions
-
Management of fish allergy based on Oral Food Challenge
-
Management of food allergy in the clinic
-
Management of food allergy in the school setting
-
Management of hypersensitivity to chemotherapy
-
Management of positive challenges in Allergy Day Hospital through the eyes of Food Allergy Severity Score (FASS score)
-
Management of reactions to chemotherapeutic drugs in children
-
Management of recurrent angioedema beyond HAE-C1INH
-
Management of severe food allergy in children
-
Management of the reactions to inodiated contrast media
-
Management of the reactions to inodiated contrast media
-
Maternal Diet Index and childhood asthma and food allergy – a replication study from Sweden
-
Maternal exercise during pregnancy is associated with reduced risk of asthma in the child: a prospective birth cohort study
-
Measurement of serum specific IgE to Ryegrass allergen component Lol p 5 in the TAISAR cohort predicts risk of Thunderstorm Asthma
-
Measuring adherence to inhaled asthma controller medication
-
Mechanisms and Predictors of Response or Failure to Biologic Therapies in Asthma and Allergy
-
Mechanisms and applications in allergy and asthma research
-
Mechanisms and management of hypersensitivity induced by specific drugs
-
Mepolizumab Improves and Sustains Asthma Control and Lung Function in Patients with Severe Asthma, Independent of Baseline IgE and FeNO in the Real World: 2-Year Results from REALITI-A
-
Mepolizumab as game changer in a case of severe occupational asthma with rhinitis and contact dermatitis
-
Mepolizumab significantly reduces clinical interventions in the management of patients with CRSwNP: post hoc analysis of SYNAPSE using a composite endpoint
-
Mepolizumab simultaneously improves clinical outcomes in severe CRSwNP and asthma in the SYNAPSE study: Focus on global airway disease
-
MicroRNA Signatures of Pediatric Obesity-Associated Asthma: Identifying Molecular Links Between Obesity and Asthma in Children
-
Mid-Term Impact of Non-Pharmaceutical Interventions on the Epidemiology of Hospitalizations for Severe Asthma Exacerbation in Children : A Time-Series Analysis
-
Model-based machine learning to understand progression of asthma through life-course
-
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities
-
Molecular Clustering Using microRNA Expression Profiles in Pediatric Asthma Reveals Differential Corticosteroid Responsiveness
-
Molecular allergen sensitizations drive phenotypes of severe asthma in children: evidence from a megacity cohort (SAMP)
-
Monitoring Patients with Severe Eosinophilic Asthma Receiving Benralizumab in Allergy Centers in Greece for 8-12 months – REALISM-A Study (gReek rEAl Life regIStry of benralizuMab among Allergists)
-
Monitoring for early warning signs of asthma attacks and response to treatment with oral corticosteroids using the Albus Home contactless monitoring system
-
Monocyte chemotactic factors in the airways of patients with asthma after an allergen challenge
-
Multicohort Analysis Profiles the Blood-Based Transcriptome Features of Adult and Childhood Asthma
-
Multidisciplinary approach in the management of hypersensitivity reactions to biological agents and successful rapid drug desensitization
-
Multiplex molecular allergy profile of allergic rhinitis patients from an allergic and asthma center, Thailand
-
Murine IgG1 increased by subcutaneous immunotherapy suppressed development of allergic asthma
-
Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)
-
Nature’s Role in Healing: Harnessing Biodiversity to Combat Asthma and Allergies
-
Navigating the asthma maze in children: insights into phenotypes, innovative treatments, and preventive measures
-
Nestlé Health Science on Pediatric Allergy: Working together to improve management of patients with food allergy
-
New horizons in the management of severe atopic dermatitis
-
New paradigm in the management of food allergy – DEFASE validation steps
-
New strategies in the treatment of severe asthma
-
News in hereditary angioedema management
-
Next-Generation cellular therapy: should CAR-T cells be considered for allergy and asthma treatment
-
Non IgE-mediated food allergy: from diagnosis to management – Session 1: Food protein-induced entrocolitis – FPIES
-
Non IgE-mediated food allergy: from diagnosis to management – Session 2: Eosinophilic esophagitis
-
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity Reactions: An approach to assessment, diagnosis, and management in a paediatric population
-
Novartis Pharma AG – Navigating the labyrinth of CSU management
-
Novel Pollen Aerosolization System for Studying Inflammation in Differentiated Airway Epithelia from Patients with Allergic Rhinitis and Asthma
-
Novelties in asthma Biomarkers and immunomodulatory pathways
-
Novelties in the diagnosis and management of children with suspicion of DRESS
-
Nutritional strategies and lifestyle management in food allergies
-
OAS3: ENT, asthma and respiratory allergy
-
Obesity Modified the Genetic Effect on Risk of Asthma: A Genome-wide Association Study of Adult Asthma
-
Occupational Asthma Due to Tenebrio Molitor in the Owner of a Mealworm Farm: A Case Report
-
Occupational asthma due to Chinese yeast, Yeast and Peptone
-
Occupational asthma in hairdressers due to hair dyes containing para-amino compounds
-
Omalizumab Combined Chinese Traditional Medicine in a Complicated Severe Asthma after Bronchial Thermoplasty
-
Omalizumab administration for the management of severe allergic keratoconjunctivitis – a 10-year experience
-
Optimising support for patients with asthma – a primary care model
-
Outcome and complications of COVID-19 among children with asthma in South Korea: a national incident cohort study
-
OverSEA: European Delphi Consensus Study on Best Practices for patients with Severe Eosinophilic Asthma and comorbid CRSwNP
-
Overview of Asthma On-Treatment Clinical Remission Data
-
PDS3: Food Allergy Management 2
-
PDS6: Food Allergy Management 1
-
PDS9: Asthma
-
PTGDR2 Blood Expression as a Potential Biomarker for Predicting Super-Response to IL-5-Targeted Therapies in Severe Asthma
-
Paediatric AD vs Food Allergy Management in the South of Ireland
-
Parasitic Infection as a risk factor for Childhood Asthma in Upper Egypt
-
Patient-Centered Approaches and the Role of Bilastine in long-term Urticaria Management
-
Patients With Moderate-to-Severe Asthma Treated With Dupilumab Are More Likely to Meet Clinical Remission Criteria: Results From the VESTIGE Trial
-
Patients undergoing immunotherapy with Alternaria alternata: prevalence of asthma and co-sensitization to other allergens
-
Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma Experience Early and Sustained Benefit with Depemokimab in the Randomised, Double-Blind, Parallel-Group, Replicate ANCHOR-1/2 Studies
-
Patients with severe eosinophilic asthma starting anti-IL5 treatment after 2018 have better preserved lung function compared to the patients who started treatment earlier
-
Peak Flow Monitoring in Asthma Control
-
Pediatric problematic severe asthma
-
Perceived Impact and Awareness of Climate Change among Climate-Vulnerable Adults with Asthma
-
Perseverance in Asthma Education: Controlling Frequent Wheezing in a schoolgirl
-
Personalized Selection of Milk Formulas for Children with Cow’s Milk Allergy and Histamine Intolerance: Intersection of Innovative Allergy Management and Sustainability
-
Personalized application of Biologics in pediatric allergy and asthma
-
Phenotypes and inflammatory molecular endotypes of chronic rhinosinusitis and its implication for asthma
-
Phenotyping Occupational Rhinitis and Asthma: Towards Better Management
-
Phenotyping and endotyping AD: implications for disease management
-
Pilocarpine in the management of allergic rhinosinusitis; a prospective, placebo-controlled study for a novel use of a cholinergic agent
-
Platinum drug hypersensitivity reactions – diagnosis and management with desensitization
-
Polyphenol concentrate reduces CRP in asthma patients who have had COVID-19
-
Post-covid immunological sequelae in children – diagnosis and management
-
Potential of biologicals usage in moderate asthma
-
Practical advances in food allergy and management
-
Practical management of cutaneous adverse drug reactions
-
Predicting Asthma in Preschool Children: The Role of Eosinophil Blood Counts During Acute Wheezing Episodes
-
Predicting pediatric asthma and airway disease
-
Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score
-
Predictive Value of Bronchodilator Reversibility and FeNO in Assessing Positive Outcomes of Bronchial Provocation Tests in Asthma Patients
-
Predictors of Asthma Development Following Rhinovirus Infection in Preschool Children
-
Predictors of Exacerbation-Prone Asthma in children: comorbidities and T2 Biomarkers with allergy sensitization
-
Predictors of biological therapy in severe asthma patients. An ambispective study from the BIOBADALER consortium
-
Predictors of biological therapy in severe asthma patients. An ambispective study from the BIOBADALER consortium
-
Predominance of eosinophilic pathogenetic mechanisms in a severe allergic asthma patient on biologic therapy
-
Preliminary analysis of microbiome and metabolomics characteristics of upper respiratory tract in school-age children with bronchial asthma
-
Prevalence and causes of AR and asthma in Mongolia
-
Prevalence of asthma as comorbidity in uncontrolled CRSwNP prior to endoscopic sinus surgery – a cross-sectional study
-
Prevalence of severe fatigue and its contributing factors in patients with severe asthma
-
Prevalence of the sensitivity to aeroallergens among patients with asthma and allergic rhinitis (AR), based on skin prick test (SPT) and its seasonal variation
-
Prevention of allergic asthma
-
Pro-inflammatory cytokines (IL-6 and TNF), influence of the JAK-STAT cascade and negative regulation of the Hyppo pathway in the severe asthma phenotype
-
Probiotics Supplementation on mitigating adverse effects of Phthalate-Induced Asthma
-
Progression of Underlying Disease in Pediatric Severe Asthma
-
Progressive increase of the intervals between omalizumab administration in severe asthma
-
Proposal of an algorithm for asthma diagnosis using molecular biomarkers
-
Prospective association between ultra-processed food consumption in childhood and the development of asthma and atopy
-
Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
-
RHINA : What can we learn from the asthma guidelines
-
RSV Infection: A Catalyst for Allergy and Asthma Development
-
Raising the Bar in Asthma Management: On-Treatment Clinical Remission
-
Ravaging land, mind and lungs: asthma is associated with PTSD in individuals exposed warzones
-
Real-Life effectiveness of a Cohort of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) and Concomitant Moderate Persistent Asthma Treated with Dupilumab
-
Real-life data analysis of severe asthma patients undergoing biologic therapy: OCS consumption and respiratory function evaluation
-
Real-life efficacy of dupilumab in patients with asthma phenotype overlap- data from a tertiary pulmonary centre
-
Real-life experience after 6 months with Tezepelumab in specialized asthma units across northern Spain
-
Real-life experience in eosinophilic granulomatosis with polyangiitis (EGPA) after 12 months with mepolizumab 300mg in specialized autoimmune and asthma units in an Universitary Hospital
-
Real-life experience with tezepelumab in severe allergic asthma
-
Real-world allergen immunotherapy effectiveness in allergic asthma
-
Real-world effectiveness of biologics in patients with severe asthma: analysis of the Korean Severe Asthma Registry (KoSAR)
-
Reduced Allergic Asthma By Soy And Its Potential Mechanism Via Plasminogen Activator Inhibitor-1
-
Reduction in Annualized Exacerbations with Rademikibart in Eosinophilic Driven, Type 2 Asthma
-
Reduction in Oral Corticosteroid Burden in Patients With Moderate-to-Severe Asthma Initiating Dupilumab in the Real-World: The RAPID Registry
-
Registry on Severe Asthma with and without biological treatment in Spain: Results of a 2 year follow-up of AlergoDATA
-
Reimagining HAE management in children*
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Relevance of IL-17-associated immune pathways and CXCL10 expression in severe childhood asthma
-
Relevance of IL-17-associated immune pathways and CXCL10 expression in severe childhood asthma
-
Remission of asthma on biological therapy: one center experience
-
Respiratory muscle functions in asthma
-
Results from the EGPAware Delphi study on Red Flags for Suspicion of Eosinophilic Granulomatosis with Polyangiitis (EGPA): current management in Europe
-
Retrospective analysis of quantitative CT characteristics of patients with severe asthma treated with biological agents: KoSAR registry
-
Review of the development and latest perspectives in 2024 on Allergic Rhinitis and its Impact on Asthma (ARIA)
-
Role of nasal cytology in patients with bronchial asthma
-
Role of sublingual immunotherapy in management of patients with moderate to severe allergic rhinitis; one year study
-
Role of the single nucleotide variants of filaggrin, thymic stromal lymphopoietin and orsomucoid-1-like protein 3 in the development of atopic bronchial asthma phenotypes in children
-
SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma
-
Selection of Biologics for Severe Pediatric Asthma with Allergic Eosinophilic Phenotype
-
Serial fractional exhaled nitric oxide measurements at and off work: usefulness for diagnosis and tertiary prevention of occupational asthma
-
Serum Levels of Cytokine in Individuals with Severe Asthma with Obesity
-
Serum Periostin Level Predicted Length of Hospital Stay in Patients with Allergic Asthma
-
Severe Asthma and Depression: the Overlooked Burden
-
Severe Asthma and Obesity: A retrospective study
-
Severe Bronchial Asthma Phenotypes in a Referral Tertiary Center in Saudi Arabia
-
Severe Eosinophilic Asthma later recognized as EGPA treated with Benralizumab
-
Severe Eosinophilic Esophagitis: the Key Role of Biologics in Disease Management
-
Severe asthma associated with hereditary angioedema type 1 and other pathologies
-
Severe asthma in pediatrics and Dupilumab after failure with Omalizumab
-
Severe asthma or COPD with eosinophilic inflammation? – from uncertainty to remission under anti-IL-5R therapy
-
Sex differences in childhood asthma are driven by a T2-high phenotype and mediated through sex-hormone metabolites
-
Sex differences in childhood asthma are driven by a T2-high phenotype and mediated through sex-hormone metabolites
-
Shifting environmental exposures: a call for evolving allergic disease management
-
Single cell sequencing to unravel asthma inflammation and remodeling
-
Skin lesions: recognition and further management
-
Stability of steroid-dependent severe asthma during 5-year follow-up
-
Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in mite allergic rhinitis patients with concomitant asthma
-
Studies on the effects of various tobacco and nicotine use methods on the course and control of asthma
-
Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
-
Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria
-
Successful Management of Primary Cold Urticaria in Medical Practitioners: A Small Case Series
-
Successful treatment of severe asthma after switch of biologics. A case report
-
Successfully managing severe asthma
-
Survey of food allergy management in cooking classes at elementary schools
-
Survey to investigate health care professionals knowledge on management of mild gastro-intestinal symptoms vs cow’s milk allergy
-
Sustained reduction in Severe Asthma Exacerbations and Hospitalisations in the 12 months after Alpine Altitude Climate Treatment
-
Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in patients with bronchial asthma due to house dust mites or pollens
-
Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml
-
Symptomatic management of ISM: Are we doing enough?
-
T2 inflammatory profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)
-
Targeted Metabolomic Profiling as a Tool for Assessing Response to Biologicals: a case of Dupilumab in Severe Allergic Asthma
-
Targeted drug-induced apoptosis in key cellular mediators of allergic asthma as a new treatment strategy
-
Targeted therapies in pediatric severe asthma
-
Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice
-
Targeting TSLP in severe asthma
-
Telemedicine as an Educational Tool Regarding Anaphylaxis Management for Parents of Children with Food Allergies
-
Tests to Diagnose Asthma
-
Tezepelumab reduces OCS use and improves sino-nasal symptoms in OCS-dependent patients with severe asthma and comorbid chronic rhinosinusitis (overall and with nasal polyps): results from the phase 3b WAYFINDER study
-
The Correlation Between Two Different Reversibility Criteria (GINA and ATS/ERS) Used in Asthma Diagnosis and the Relationship Between the Concordance of These Criteria and Phenotypic Features
-
The Cross-Canada Registry for Anaphylaxis Fatalities (CRAFT ): Demographics , Triggers, Co-factors and Management
-
The Eosinophil in Obstructive Airway Disease – Beyond Asthma
-
The Fundamental Role of Education in Achieving Control in a Child with Severe Uncontrolled Asthma
-
The HMOS 2’FL and 3FL prevent house dust mite induced proinflammatory cytokine release in vitro and decrease HDM-specific IgE in an allergic asthma murine model
-
The Heterogenicity of asthma
-
The Hidden Costs of Severe Asthma Treatment: Unveiling the Iatrogenic Burden
-
The Impact of Excess Weight and Obesity on Asthma Control in a Pediatric Population
-
The Impact of Obesity in Asthma and Small Airway Dysfunction: Prevalence, Clinical characteristics, and Predictors
-
The Respiratory Microbiota and Serum Metabolomics Characteristics in Different Endotypes of Asthma
-
The Role of Anti-IgE in the Management of Food Allergy
-
The Role of Asthma and COVID-19 in Shaping the Severity of Pediatric Mycoplasma pneumoniae Infections: A Regional Perspective from the United States
-
The Role of Inflammatory Parameters in Predicting Allergy in Childhood Asthma
-
The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis with and without concomitant asthma – results from a global phase III clinical trial
-
The Use of Long-acting Muscarinic Antagonist (LAMA) in the Treatment of Asthma: A Tertiary Asthma Center Experience
-
The burden of allergic diseases and asthma – results from the HEAD registry
-
The challenge of chronic urticaria management
-
The clinical case scenarios for management of drug allergy: to provoke, treat through, or desensitize
-
The diagnostic value of peripheral blood cell parameters, fractional exhaled nitric oxide, serum total IgE and lung function in eosinophilic asthma
-
The distinctive apoptosis pathways of late-phase allergic asthma in bronchial immune cells
-
The dynein adaptor Hook2 as microtubule-based transport and anchors for organelles is involved in asthma pathogenesis
-
The effect of early exposure to pet animals on allergy and asthma development
-
The effect of tezepelumab treatment on the incidence of asthma exacerbations co-occurring with acute respiratory illnesses attributed to infections: results from a pooled analysis of the PATHWAY and NAVIGATOR studies
-
The effect of the community of residence on Wheeze/ asthma symptoms mediated through environmental risk factors and respiratory infection in children in southern Nigeria
-
The epidemiological consequences of the war on asthma incidence
-
The expanding field of Primary Atopic Disorders and their management
-
The gut fungome is associated with future risk of exacerbations, asthma control and quality of life in children with uncontrolled asthma: results from the PUFFIN study
-
The impact of Type 2- targeted biological therapies on persistent cough in adults with cough variant- or cough predominant asthma
-
The impact of asthma and mental health condition multimorbidity in national samples of Canadian children
-
The impact of second-hand exposure to e-cigarette on asthma exacerbations in the pediatric population
-
The impact of wartime environmental change on the frequency of asthma diagnoses
-
The importance of breathing exercises in the rehabilitation of allergic asthma in children
-
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
-
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
-
The interaction of exposure to air pollutants and inflammatory markers on lung function and asthma symptoms in asthmatic patients
-
The m6A demethylase FTO mediates type 2 inflammation in asthma by regulating STAT6 mRNA stability
-
The modulation of ICAM-1 and ICAM-3 is mediated by alarmins in severe eosinophilic asthma
-
The new nomenclature for asthma and allergy
-
The parasympathetic nervous system plays a key role in control and stress in patients with asthma
-
The potential of anti-infectives and immunomodulators in pediatric asthma
-
The prevalence and management features of adolescents with atopic dermatitis under humanitarian crisis
-
The puzzling journey of asthma diagnosis – the IPCRG’s new educational approach.
-
The relevance of IL-5 biology in severe asthma
-
The role allergic sensitization in severe asthma
-
The role of T cell regulation and airway remodelling in asthma
-
The role of mucus in asthma and CRS severity
-
The significance of FeNO test in patients with different asthma endotypes
-
The treatment of eosinophilic asthma with mepolizumab and benralizumab: relative effectiveness
-
The triple type 2 signature is associated to asthma severity and comorbidity with CRS
-
The usefulness of atopy patch tests for the diagnosis and management of children with Non-IgE-mediated gastrointestinal Food Allergy: results of the NIGEFA project
-
The usefulness of atopy patch tests for the diagnosis and management of children with Non-IgE-mediated gastrointestinal Food Allergy: results of the NIGEFA project
-
The usefulness of the forced oscillation technique in the diagnosis of bronchial asthma in seniors
-
The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma
-
To study intra-breath variability in oscillometric parameters with level of asthma control among children from North India
-
Toward Optimal disease control: impact of maintenance inhaler therapy and device transition in severe asthma patients undergoing monoclonal antibody treatment
-
Towards a Treat to Target approach in asthma: Asthma remission
-
Transforming severe asthma respiratory care: the clinical experience
-
Treatment of different asthma endotypes
-
Treatment of severe asthma (update)
-
Triggers and Mechanisms of Asthma Exacerbations: One Outcome, Many Paths?
-
Tumor necrosis factor-alpha in allergic inflammation in overweight children with asthma
-
Turkish National Hereditary Angioedema and Acquired Angioedema Registry, Established to Encourage Standardizing the Care and Management of the Disease. HAE/AAE-TR National Hereditary and Acquired Angioedema Registry Group
-
Two Cases of Multiple Drug Hypersensitivity: Diagnosis and Clinical Management
-
Two cases of discrepancy between fractional exhaled nitric oxide and airway eosinophils in asthma
-
Type 2-high airway inflammation in childhood asthma distinguishes a more severe phenotype
-
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity
-
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity
-
Unmasking mastocytosis: a step-by-step management plan
-
Untargeted metabolomics reveals the metabolic profiles of children with allergic asthma in eastern and western China
-
Updates in the clinical management of allergen immunotherapy
-
Urban Forest Fungal Microbiome Diversity and Its Impact on Asthma and Allergic Inflammation
-
Use of biologics in severe uncontrolled asthma at National Institute of Pediatrics 2020-2023
-
Use of biologics in severe uncontrolled asthma at National Institute of Pediatrics 2020-2023
-
Trends in Sensitization to Pet Allergens and Correlation between Symptoms and Asthma in Allergic Rhinitis from 2017 to 2023 in China
-
Trends in the prevalence of asthma in Korean children: a population-based study from 1995 to 2022
-
Use of the AllergyVax Doctor app to evaluate the correlation between adherence to treatment and control of rhinitis and asthma in patients during treatment with SLIT
-
Utility of molecular allergology in diagnosis and management of complex sensitization profiles
-
Variables predicting clinical remission among adults with severe asthma treated with biologic agents
-
Viral infections and asthma exacerbations.
-
Vitamin D3 deficiency is more common in children with asthma than in children with other allergic diseases
-
War related exposures and asthma development
-
What are the new strategies in the management of food allergy?
-
What are the predictors of asthma remission and what can we modify?
-
What is asthma remission and what can we learn from other autoimmune and inflammatory disease about remission?
-
Wheeze phenotypes in infants whose mothers have asthma
-
When and how it starts: unveiling the early development of asthma in preschool years
-
Xiaoqinglong Decoction Combined with Yupingfeng Powder Alleviates Allergic Rhinitis Complicated with Asthma by Inhibiting B Lymphocyte Activation via JAK2/STAT1/MHC-II signaling pathway
-
“Can Do, Do Do“ in patients with severe uncontrolled asthma referred for pulmonary rehabilitation in the alpine climate
-
Allergy and Asthma – Session 1: Diagnosing Asthma
-
Allergy and Asthma – Session 2: Precision medicine in pediatric asthma
-
Application of Smart Wearable Devices in Management of Asthma
-
Association of asthma severity with high sensitivity C-reactive protein (hsCRP) in the all-age asthma cohort ALLIANCE
-
Asthma Severity and Patient-Reported Outcomes in Patients With Asthma and Allergic Rhinitis Initiating Dupilumab in RAPID
-
Asthma control, lung function, and quality of life in pediatric patients with severe asthma undergoing biological treatment
-
Asthma management in the digital age
-
Basophil FceRI expression-A management tool in anti-IgE treatment of allergic asthma
-
Breathing Easier: Cutting-Edge Advances in Paediatric Asthma Management
-
Case Report: Management of Severe Asthma and Multiple Food Allergies with Omalizumab. Outcomes Following an 18-Month Step-Down Therapy
-
Characteristics of severe eosinophilic asthma in childhood-onset and adult-onset asthma in U-BIOPRED
-
Decoding Asthma Therapies: Transcriptomic differences between benralizumab and mepolizumab treatment in patients with severe eosinophilic asthma
-
Distribution of IL-1β Expression in Asthma Patients and Comparison of Therapeutic Efficacy of Different Administration Routes of IL-1β Neutralizing Antibody in a Mouse Model of Asthma
-
Dupilumab Reduces Exacerbations and Improves Asthma Control in Children With Moderate-to-Severe Type 2 Asthma, Regardless of Asthma Duration
-
Effectiveness of allergy immunotherapy on asthma medication use and asthma exacerbations: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study
-
Evaluation of Asthma Course in Patients Hospitalized in Pediatric Intensive Care Unit Due to Severe Asthma Exacerbation
-
Evaluation of the concordance of definitions of Asthma Remission according to international guidelines in a cohort of patients treated with monoclonal antibodies for severe asthma
-
Exercise recommendations and practical considerations for asthma management
-
Focus on exercise and asthma management
-
Improving severe asthma through psychological management of traumatic life events
-
Inhaled Corticosteroid Reduction Effects on Asthma Outcomes after Three Years of Benralizumab Treatment in Severe Asthma Patients
-
Key considerations in the management of asthma
-
Management Challenges in Pediatric Asthma with Long QT Syndrome
-
Management of allergic asthma
-
Mepolizumab Improves and Sustains Asthma Control and Lung Function in Patients with Severe Asthma Independent of Baseline Blood Eosinophil Count in the Real World: Results from REALITI-A at 2 Years
-
Optimising asthma management in children
-
Post-emergency asthma management
-
Practical Guide to Biomarker-Driven Pediatric Asthma Management
-
Real-world change in asthma symptom control and oral corticosteroid use in patients with severe asthma treated with mepolizumab stratified by atopic status: Post hoc analysis of REALITI-A at 2 years
-
Root and branch of childhood asthma management
-
Serum cytokine profiles of pediatric normal weight asthma and overweight/obese asthma and their correlation with pulmonary function indices
-
Severe asthma and sleep disorders: a Severe Asthma Network Italy (SANI) analysis
-
The Effectiveness of Educational Interventions on Asthma Management in Children in Primary care settings: Systematic Review of Randomised Control Trials
-
The relationship between asthma duration and biomarker profiles in severe asthma
-
Unique role of Candida albicans sensitization in management of asthma patients living underground during military operations in Ukraine
-
Voice biomarkers: a new tool for asthma management
-
Worse asthma control in patients with asthma and respiratory allergies in the CAPTURE study: Rationale for developing the RespiratoryAllergyOptimiser
-
Characteristics and Asthma Control Status of Severe Asthma Patients in the Korean Severe Asthma Registry-2 (KoSAR-2)
-
Characteristics of asthma phenotypes: Does coexistence of allergic and eosinophilic asthma increase asthma severity?
Show more Sessions (679)Show Less-
-
Cover the Latest Developments in Allergy and Asthma at the EAACI Congress 2024 in Valencia, Spain
-
EAACI Launches Second Phase of Groundbreaking Allergy Management Project
-
EAACI Unveils Groundbreaking Guidelines for IgE-Mediated Food Allergy Management
-
Explore our EAACI Knowledge Hub Module: Towards precise management of drug allergy
-
Launch of the PAI Virtual Issue on Asthma & Environment
-
Take the EAACI Survey: Exercise and Physical Activity for Asthma Management
-
Take the survey by the EAACI Task Force: Improving Chronic Urticaria Management in Pediatrics – (ICUMP) Management (2)
Show more News (5)Show Less-
-
Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI)
-
Cuban Society of Allergy, Asthma and Clinical Immunology (CSAACI)
-
Iranian Society of Asthma and Allergy
-
Kosovo Immunology Asthma and Allergy Association (KIAAA)
-
Saudi Allergy Asthma & Immunology Society (SAAIS)
-
Society of Pediatric Allergy Immunology and Asthma (CAIAD)
-
Spanish Pediatric Society of Clinical Immunology, Allergy and Asthma (SEICAP)
Show more Member societies (5)Show Less-